Candel Therapeutics CADL
Price chart
Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.
Community Sentiment on CADL
Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Strategy Backtest
Pick a strategy above and run the backtest to see its simulated performance on CADL.
Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.
CADL at a glance
Shares of Candel Therapeutics are up 8.83% at $8.75. The company is worth $669.54M, number 3498 out of 3753 on our list.
Over a full year the shares have ranged across $4.35 to $14.00, which puts the current price roughly 46% of the way up that band. Holders are ahead 73.6% over twelve months, but down 16.7% across the last three months.
Price is below the 50-day average ($10.20) but above the 200-day ($8.34); RSI is 47, and the last 30 sessions moved at roughly 71% annualized volatility.
For the quarter ended Jun 2026 it reported $0.00 in revenue, and a net loss of $38.91M.
6 analysts follow the stock and the average call is "buy". The mean target, $21.50, sits 145.7% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
BeStock Grade
Composite of 3 factors below, ranked against the 3741 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Trading closer to its 52-week high than most peers scores higher.
6 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
BeStock Momentum
CADL is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-12-28, the strategy has returned 437.6% (204.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.
Price forecast
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $21.50, 145.7% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $12.13, so shares trade 27.9% below that estimate. On earnings multiple, it sits in the 28th percentile of its own five-year valuation range (cheaper than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Performance
Price return over each window, from adjusted daily and weekly closes
Technical signals
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | +2.1% | Bullish |
| Price vs 50-day average | -14.2% | Bearish |
| Price vs 200-day average | +4.9% | Bullish |
| 50-day vs 200-day | 50d above 200d | Bullish |
| RSI (14) | 47.1 | Bearish |
| MACD (12,26,9) | -0.44 | Bullish |
| Bollinger band position | 59% | Bullish |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Key statistics
Quote as of Nov 6, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
How CADL ranks on BeStock
Ranks are among the 3,741 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
CADL stock: common questions
Where is CADL trading right now?
$8.75 is the latest print for CADL, a move of +8.83% against yesterday's close of $8.04. Today's low and high so far: $8.06 and $8.75.
How large is Candel Therapeutics by market value?
Equity value comes to $669.54M at the current price. By that measure it is number 3498 of the 3753 names in our coverage.
Is CADL near its 52-week high or low?
The year's floor is $4.35 and the ceiling $14.00. Shares are 37.5% away from that ceiling.
Does Candel Therapeutics pay a dividend?
Our data shows no dividend paid by Candel Therapeutics over the trailing twelve months.
Is CADL rated a buy by Wall Street?
Of 6 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $21.50, with the most cautious at $16.00 and the most optimistic at $25.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on CADL.